Assessment of the clinical benefits of remote monitoring of cardiac-implanted devices: A single-center study in Japan

Assessment of the clinical benefits of remote monitoring of cardiac-implanted devices: A single-center study in Japan

Introduction: The clinical benefits of remote monitoring (RM) of cardiac-implanted devices have not been fully evaluated in Japan. We investigated the clinical benefits of RM in a single center in Japan. Methods: Patients with pacemakers, implantable cardioverter-defibrillators (ICD), or cardiac res...

Full description

Bibliographic Details
Main Authors:	Konomi Togo, Masahiko Takagi, MD, PhD, Kentaro Suzuki, MD, Keiko Maeda, MD, Hiroaki Tatsumi, MD, Kazuhide Takeuchi, MD, PhD
Format:	Article
Language:	English
Published:	Wiley 2013-02-01
Series:	Journal of Arrhythmia
Subjects:	Pacemaker Implantable cardioverter-defibrillator Cardiac resynchronization therapy Remote device follow-up
Online Access:	http://www.sciencedirect.com/science/article/pii/S1880427612001081

Similar Items

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Unusual fracture in a Durata lead with shock coil fragmentation and cable externalization
by: Toshiaki Sato, MD, et al.
Published: (2017-07-01)

New horizon for infection prevention technology and implantable device
by: Yusuke Kondo, MD, PhD, et al.
Published: (2016-08-01)

Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations
by: Antonino M. Grande, MD, et al.
Published: (2015-12-01)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
by: Justin Hayase, MD, et al.
Published: (2018-02-01)

Triple atrial sensing during cardiac resynchronization
by: S. Serge Barold, et al.
Published: (2020-02-01)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
by: Mohammad Ali Akbarzadeh, MD, et al.
Published: (2017-02-01)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
by: Michele Murphy, MD, et al.
Published: (2016-11-01)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
by: S.P. Abhilash, et al.
Published: (2013-05-01)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
by: Hisashi Yokoshiki, MD, PhD, et al.
Published: (2017-10-01)

Electromagnetic Interference with Cardiac Implantable Devices by Household and Industrial Appliances
by: Tomohide Yonemura, et al.
Published: (2011-01-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

In vitro Assessment of Electromagnetic Interference due to Low-Band RFID reader/writers on Active Implantable Medical Devices
by: Shunichi Futatsumori, PhD, et al.
Published: (2009-01-01)

Unregulated online sales of cardiac implantable electronic devices in the United States: A six-month assessment
by: Bolanle Akinyele, MD, et al.
Published: (2020-10-01)

Variation in Lead Impedance according to Pacemaker Analyzing Systems
by: Hiroshi Ichiyanagi, et al.
Published: (2010-01-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Device therapy in pediatric and congenital heart disease patients
by: Naokata Sumitomo, MD, PhD
Published: (2014-12-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Management of device-related malignant sarcoma
by: Arash Khamooshian, MD, et al.
Published: (2017-08-01)

AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol
by: Valentina Kutyifa, MD, PhD, FHRS, et al.
Published: (2020-12-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

B-Cell lymphoma at the site of pacemaker generator
by: Andreas Keyser, MD, et al.
Published: (2020-08-01)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2020-08-01)

Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)

Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis
by: Toshiya Kojima, et al.
Published: (2012-08-01)

Automatic switching between the AAI and the DDD algorithm can prevent repetitive non-reentrant ventriculoatrial synchrony
by: Takeshi Kitamura, MD, et al.
Published: (2014-04-01)

Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
by: John Fanourgiakis, et al.
Published: (2016-01-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Involving patients as key stakeholders in the design of cardiovascular implantable electronic device data dashboards: Implications for patient care
by: Carly Daley, MS, et al.
Published: (2020-06-01)

A Single Shock During An Episode Of Ventricular Tachycardia: Is The Device Working Properly?
by: Jesus Jimenez-Lopez, MD, et al.
Published: (2012-09-01)

Radiofrequency ablation–assisted extraction of a pacing lead fragment
by: J. William Schleifer, MD, et al.
Published: (2015-07-01)

Lead management in setting of limited venous accesses: A case report and review of literature
by: Mohsin Khan, MD, et al.
Published: (2021-08-01)

Decline in physical activity in the weeks preceding sustained ventricular arrhythmia in women
by: Ashley E. Burch, PhD, et al.
Published: (2020-10-01)

“Add-on pacing lead”: An effective and safe alternative to lead replacement in ICD pacing failure
by: Sudeep Kumar, et al.
Published: (2012-07-01)

New Therapy, New Complications∗
by: Jedrzej Kosiuk, MD, et al.
Published: (2020-02-01)

Wire countertraction for sheath placement through stenotic and tortuous veins: The “body flossing” techniqueKey Findings
by: Jeffrey S. Arkles, MD, FHRS, et al.
Published: (2020-04-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report
by: Takashi Kanda, MD, et al.
Published: (2015-06-01)